The risk of liver cancer in autoimmune liver diseases.

Lleo, Ana; de Boer, Ynto S; Liberal, Rodrigo; Colombo, Massimo

Lleo, Ana; de Boer, Ynto S; Liberal, Rodrigo; Colombo, Massimo.

Afiliación

Lleo A; Department of Biomedical Sciences, Humanitas University, Division of Internal Medicine and Hepatology, Department of Gastroenterology, Humanitas Clinical and Research Center IRCCS, Via A. Manzoni 56, 20089 Rozzano (MI), Italy.
de Boer YS; Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers - VU University Medical Center, The Netherlands.
Liberal R; Institute of Liver Studies, King's College London, UK.
Colombo M; Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy.

Ther Adv Med Oncol ; 11: 1758835919861914, 2019.

Article en En | MEDLINE | ID: mdl-31320937

Palabras clave

autoimmune hepatitis; autoimmune liver diseases; cholangiocarcinoma; hepatic cancer; hepatocellular carcinoma; primary biliary cholangitis; primary sclerosing cholangitis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Guideline / Risk_factors_studies / Screening_studies Idioma: En Revista: Ther Adv Med Oncol Año: 2019 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google